Avanos Medical (AVNS) Net Income (QoQ) (2013 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 81.25% |
| Sep 30, 2024 | 36.00% |
| Jun 30, 2024 | -78.57% |
| Mar 31, 2024 | -180.00% |
| Dec 31, 2023 | -109.80% |
| Sep 30, 2023 | 107.99% |
| Jun 30, 2023 | -973.97% |
| Mar 31, 2023 | 1.39% |
| Dec 31, 2022 | 53.19% |
| Sep 30, 2022 | -38.96% |
| Jun 30, 2022 | 42.59% |
| Mar 31, 2022 | 121.01% |
| Dec 31, 2021 | 27.20% |
| Sep 30, 2021 | -191.69% |
| Jun 30, 2021 | 558.33% |
| Mar 31, 2021 | 82.86% |
| Dec 31, 2020 | -353.89% |
| Sep 30, 2020 | 743.33% |
| Jun 30, 2020 | -181.08% |
| Jun 30, 2018 | 7.94% |
| Mar 31, 2018 | 10.92% |
| Dec 31, 2017 | 5.97% |
| Sep 30, 2017 | -5.96% |
| Jun 30, 2017 | 2.89% |
| Mar 31, 2017 | 124.49% |
| Dec 31, 2016 | -1,342.86% |
| Sep 30, 2016 | 40.00% |
| Jun 30, 2016 | -54.23% |
| Mar 31, 2016 | -95.82% |
| Dec 31, 2015 | 172.18% |
| Sep 30, 2015 | -5,981.25% |
| Jun 30, 2015 | -63.13% |
| Mar 31, 2015 | 1,004.17% |
| Dec 31, 2014 | 67.57% |
| Sep 30, 2014 | -64.44% |
| Jun 30, 2014 | -110.87% |
| Mar 31, 2014 | 4.02% |
| Dec 31, 2013 | -16.91% |